乳腺MRI假阴性结果:原因与防范策略
乳腺MRI是检出乳腺癌最敏感的模态,但假阴性仍可发生。本文将该类假阴性归因于感知错误、认知错误及肿瘤不强化所致未显示,并讨论避免上述错误的策略。某些乳腺癌亚型(导管原位癌、浸润性小叶癌及部分高分化浸润性癌)因血管生成差异可表现为几乎不强化。
要点
- 假阴性可源于感知错误(异常未被前瞻性识别)或认知错误(异常被误判为良性)。
- 利用既往检查对比、多平面观察及整合增强、T2、T1与临床信息可减少认知错误。
- 导管原位癌、浸润性小叶癌及部分高分化浸润性癌可几乎不强化而致MRI未显示。
关键影像表现/征象
- 感知错误指检查技术充分但异常未被前瞻性识别。
- 认知错误指异常被识别但被误判或误分类为良性。
- 某些乳腺癌亚型(导管原位癌、浸润性小叶癌及部分高分化浸润性癌)因血管生成和新血管形成差异可表现为几乎不强化。
临床应用与阅片要点
- 建立细致的搜索模式以避免感知错误。
- 利用所有可获得的既往检查进行对比。
- 在多平面观察图像以更好评估异常的边缘和形状。
- 适当整合增强、T2加权和T1加权图像信息及临床病史。
- MRI应继续与乳腺X线和US联合作为补充模态用于乳腺癌检出。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast MRI is the most sensitive modality for the detection of breast cancer. However, false-negative cases may occur, in which the cancer is not visualized at MRI and is instead diagnosed with another imaging modality. The authors describe the causes of false-negative breast MRI results, which can be categorized broadly as secondary to perceptual errors or cognitive errors, or nonvisualization secondary to nonenhancement of the tumor. Tips and strategies to avoid these errors are discussed. Perceptual errors occur when an abnormality is not prospectively identified, yet the examination is technically adequate. Careful development of thorough search patterns is critical to avoid these errors. Cognitive errors occur when an abnormality is identified but misinterpreted or mischaracterized as benign. The radiologist may avoid these errors by utilizing all available prior examinations for comparison, viewing images in all planes to better assess the margins and shapes of abnormalities, and appropriately integrating all available information from the contrast-enhanced, T2-weighted, and T1-weighted images as well as the clinical history. Despite this, false-negative cases are inevitable, as certain subtypes of breast cancer, including ductal carcinoma in situ, invasive lobular carcinoma, and certain well-differentiated invasive cancers, may demonstrate little to no enhancement at MRI, owing to differences in angiogenesis and neovascularity. MRI is a valuable diagnostic tool in breast imaging. However, MRI should continue to be used as a complementary modality, with mammography and US, in the detection of breast cancer. ©RSNA, 2021.
引用
- Korhonen KE, Zuckerman SP, Weinstein SP, et al. Breast MRI: False-Negative Results and Missed Opportunities. Radiographics. 2021. PMID: 33739893. doi:10.1148/rg.2021200145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。